1)Habib G, et al:Guidelines on the prevention, diagnosis, and treatment of infective endocarditis(new version 2009):The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology(ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases(ESCMID)and the International Society of Chemotherapy(ISC)for Infection and Cancer. Eur Heart J 30:2369-2413, 2009
2)Chu VH, et al:Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 46:232-242, 2008
3)Holland TL, et al:Clinical management of Staphylococcus aureus bacteremia;A review. JAMA 312:1330-1341, 2014
4)Baddour LM, et al:Infective endocarditis;Diagnosis, antimicrobial therapy, and management of complications;A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association;Endorsed by the Infectious Diseases Society of America. Circulation 111:e394-434, 2005
5)Mermel LA, et al:Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection;2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1-45, 2009
6)Gould FK, et al:Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults;A report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 67:269-289, 2012
7)von Eiff C, et al:Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2:677-685, 2002
8)Cosgrove SE, et al:Management of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 46:S386-393, 2008